These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26024386)

  • 1. Are PEGylated liposomes better than conventional liposomes? A special case for vincristine.
    Wang X; Song Y; Su Y; Tian Q; Li B; Quan J; Deng Y
    Drug Deliv; 2016 May; 23(4):1092-100. PubMed ID: 26024386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
    Krishna R; Webb MS; St Onge G; Mayer LD
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer.
    Webb MS; Logan P; Kanter PM; St-Onge G; Gelmon K; Harasym T; Mayer LD; Bally MB
    Cancer Chemother Pharmacol; 1998; 42(6):461-70. PubMed ID: 9788572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a stable single-vial liposomal formulation for vincristine.
    Mao W; Wu F; Lee RJ; Lu W; Wang J
    Int J Nanomedicine; 2019; 14():4461-4474. PubMed ID: 31296986
    [No Abstract]   [Full Text] [Related]  

  • 5. Vincristine sulfate liposome injection: a guide to its use in refractory or relapsed acute lymphoblastic leukemia.
    Harrison TS; Lyseng-Williamson KA
    BioDrugs; 2013 Feb; 27(1):69-74. PubMed ID: 23329395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?
    Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Xiu X; Li Y; Wei N
    J Pharm Sci; 2011 Jul; 100(7):2835-48. PubMed ID: 21305545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates.
    Shah NN; Cole DE; Lester-McCully CM; Wayne AS; Warren KE; Widemann BC
    Invest New Drugs; 2016 Feb; 34(1):61-5. PubMed ID: 26661090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.
    Crosasso P; Ceruti M; Brusa P; Arpicco S; Dosio F; Cattel L
    J Control Release; 2000 Jan; 63(1-2):19-30. PubMed ID: 10640577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo administration of liposomal vincristine sensitizes drug-resistant human solid tumors.
    Leonetti C; Scarsella M; Semple SC; Molinari A; D'Angelo C; Stoppacciaro A; Biroccio A; Zupi G
    Int J Cancer; 2004 Jul; 110(5):767-74. PubMed ID: 15146568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
    Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
    J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
    Semple SC; Leone R; Wang J; Leng EC; Klimuk SK; Eisenhardt ML; Yuan ZN; Edwards K; Maurer N; Hope MJ; Cullis PR; Ahkong QF
    J Pharm Sci; 2005 May; 94(5):1024-38. PubMed ID: 15793796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.
    Webb MS; Harasym TO; Masin D; Bally MB; Mayer LD
    Br J Cancer; 1995 Oct; 72(4):896-904. PubMed ID: 7547237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug.
    Boehlke L; Winter JN
    Expert Opin Biol Ther; 2006 Apr; 6(4):409-15. PubMed ID: 16548767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine.
    Webb MS; Saxon D; Wong FM; Lim HJ; Wang Z; Bally MB; Choi LS; Cullis PR; Mayer LD
    Biochim Biophys Acta; 1998 Jul; 1372(2):272-82. PubMed ID: 9675310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA approves liposomal vincristine (Marqibo) for rare leukemia.
    Oncology (Williston Park); 2012 Sep; 26(9):841. PubMed ID: 23061340
    [No Abstract]   [Full Text] [Related]  

  • 16. Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias.
    Shah NN; Merchant MS; Cole DE; Jayaprakash N; Bernstein D; Delbrook C; Richards K; Widemann BC; Wayne AS
    Pediatr Blood Cancer; 2016 Jun; 63(6):997-1005. PubMed ID: 26891067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine.
    Silverman JA; Deitcher SR
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):555-64. PubMed ID: 23212117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged circulation and increased tumor accumulation of liposomal vincristine in a mouse model of rhabdomyosarcoma.
    Roveri M; Pfohl A; Jaaks P; Alijaj N; Leroux JC; Luciani P; Bernasconi M
    Nanomedicine (Lond); 2017 May; 12(10):1135-1151. PubMed ID: 28447920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG
    Song XL; Liu S; Jiang Y; Gu LY; Xiao Y; Wang X; Cheng L; Li XT
    Eur J Pharm Sci; 2017 Jan; 96():129-140. PubMed ID: 27644895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of a novel lipophilic folate receptor targeting ligand.
    Liu Y; Xu S; Teng L; Yung B; Zhu J; Ding H; Lee RJ
    Anticancer Res; 2011 May; 31(5):1521-5. PubMed ID: 21617205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.